Literature DB >> 9635852

Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.

M I Koukourakis1, A Giatromanolaki, S Kakolyris, K J O'Byrne, N Apostolikas, J Skarlatos, K C Gatter, A L Harris.   

Abstract

Angiogenesis is recognized as an important step in tumour pathogenesis that is related to invasion and metastatic spread and which consequently results in poor clinical outcome. In this study, we have examined the role of tumour stroma-activated fibroblasts and macrophage infiltration in the development of the angiogenic and metastatic phenotype in non-small-cell lung cancer (NSCLC). A total of 141 cases of early stage I-II NSCLC treated with surgery alone were analysed. The JC-70 (anti-CD31) MAb was used for the assessment of vascular grade. The P-GF.44C MAb was used to assess thymidine phosphorylase (TP) reactivity in cancer cells, stromal fibroblasts and macrophages. Cancer cell TP overexpression related to high vascular grade and to advanced T stage (P = 0.0004 and P = 0.02). Expression of TP in stromal fibroblasts also correlated with high angiogenesis (P = 0.01), but was independent of cancer cell expression. Fibroblast TP overexpression was related to abundant stroma (P = 0.003), suggesting that TP may be a marker of active stroma. Moreover, intense macrophage infiltration was associated with fibroblast TP reactivity, regardless of the amount of stroma, suggesting that macrophages may be a major contributor to TP expression in stroma. Survival analysis showed that cancer cell TP overexpression was related to poor prognosis (P = 0.005). Although stroma TP is related to angiogenesis, in the low vascular grade group it defined a group of patients with better prognosis (P = 0.02). It may be that fibroblast TP reactivity is an indirect marker of tumour infiltration by functional macrophages, which have an antitumour effect. We conclude that stromal macrophage and fibroblast TP reactivity may have an important role in non-small-cell lung cancer behaviour. Understanding the role of stromal fibroblasts and inflammatory cells and their interaction with oncoprotein expression is essential for the elucidation of lung cancer pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9635852      PMCID: PMC2150048          DOI: 10.1038/bjc.1998.280

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  29 in total

Review 1.  Molecular and biological properties of the vascular endothelial growth factor family of proteins.

Authors:  N Ferrara; K Houck; L Jakeman; D W Leung
Journal:  Endocr Rev       Date:  1992-02       Impact factor: 19.871

2.  JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections.

Authors:  D V Parums; J L Cordell; K Micklem; A R Heryet; K C Gatter; D Y Mason
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

3.  Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity.

Authors:  K Usuki; J Saras; J Waltenberger; K Miyazono; G Pierce; A Thomason; C H Heldin
Journal:  Biochem Biophys Res Commun       Date:  1992-05-15       Impact factor: 3.575

4.  Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor.

Authors:  F Ishikawa; K Miyazono; U Hellman; H Drexler; C Wernstedt; K Hagiwara; K Usuki; F Takaku; W Risau; C H Heldin
Journal:  Nature       Date:  1989-04-13       Impact factor: 49.962

5.  Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1.

Authors:  L A DiPietro; P J Polverini
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

6.  Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine.

Authors:  H Eda; K Fujimoto; S Watanabe; M Ura; A Hino; Y Tanaka; K Wada; H Ishitsuka
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

7.  Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.

Authors:  E R Horak; R Leek; N Klenk; S LeJeune; K Smith; N Stuart; M Greenall; K Stepniewska; A L Harris
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

8.  Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity.

Authors:  A Moghaddam; R Bicknell
Journal:  Biochemistry       Date:  1992-12-08       Impact factor: 3.162

Review 9.  The fibroblast growth factor family: structural and biological properties.

Authors:  M Klagsbrun
Journal:  Prog Growth Factor Res       Date:  1989

10.  Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer.

Authors:  M Toi; K Inada; S Hoshina; H Suzuki; S Kondo; T Tominaga
Journal:  Clin Cancer Res       Date:  1995-09       Impact factor: 12.531

View more
  33 in total

1.  Thymidine phosphorylase expression in endometrial carcinomas.

Authors:  E Sivridis; A Giatromanolaki; M I Koukourakis; R Bicknell; A L Harris; K C Gatter
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Alveolar macrophage function is altered in patients with lung cancer.

Authors:  D S Pouniotis; M Plebanski; V Apostolopoulos; C F McDonald
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

Review 3.  Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.

Authors:  Adam J Bograd; Kei Suzuki; Eva Vertes; Christos Colovos; Eduardo A Morales; Michel Sadelain; Prasad S Adusumilli
Journal:  Cancer Immunol Immunother       Date:  2011-09-13       Impact factor: 6.968

4.  Thymidine phosphorylase expression in progression of cervical cancer: correlation with microvessel count, proliferating cell nuclear antigen, and apoptosis.

Authors:  R Fujiwaki; K Hata; K Iida; Y Maede; M Koike; K Miyazaki
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

5.  Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress.

Authors:  E Sivridis; A Giatromanolaki; M I Koukourakis
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

6.  The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer.

Authors:  Alexandra Giatromanolaki; Michael I Koukourakis; Anastasios Koutsopoulos; Savvas Mendrinos; Efthimios Sivridis
Journal:  Cancer Biol Ther       Date:  2012-08-16       Impact factor: 4.742

7.  Diversity of the angiogenic phenotype in non-small cell lung cancer.

Authors:  Marc R McClelland; Shannon L Carskadon; Liujian Zhao; Eric S White; David G Beer; Mark B Orringer; Allan Pickens; Andrew C Chang; Douglas A Arenberg
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-01       Impact factor: 6.914

8.  Macrophage expression of tartrate-resistant acid phosphatase as a prognostic indicator in colon cancer.

Authors:  Joan How; Jason R Brown; Sasha Saylor; David L Rimm
Journal:  Histochem Cell Biol       Date:  2014-01-16       Impact factor: 4.304

9.  Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation.

Authors:  J Scott Brockenbrough; Janice K Morihara; Stephen E Hawes; Joshua E Stern; Janet S Rasey; Linda W Wiens; Qinghua Feng; Hubert Vesselle
Journal:  J Histochem Cytochem       Date:  2009-08-03       Impact factor: 2.479

10.  Cooperation between monocytes and breast cancer cells promotes factors involved in cancer aggressiveness.

Authors:  E Blot; W Chen; M Vasse; J Paysant; C Denoyelle; J-Y Pillé; L Vincent; J-P Vannier; J Soria; C Soria
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.